THE SOUTHAMPTON RHEUMATOLOGY CLINIC LIMITED
Company number 11093071
- Company Overview for THE SOUTHAMPTON RHEUMATOLOGY CLINIC LIMITED (11093071)
- Filing history for THE SOUTHAMPTON RHEUMATOLOGY CLINIC LIMITED (11093071)
- People for THE SOUTHAMPTON RHEUMATOLOGY CLINIC LIMITED (11093071)
- More for THE SOUTHAMPTON RHEUMATOLOGY CLINIC LIMITED (11093071)
Date (document was filed at Companies House) | Type | Description (of the document filed at Companies House) | View / Download (PDF file, link opens in new window) |
---|---|---|---|
04 Dec 2023 | CS01 | Confirmation statement made on 3 December 2023 with no updates | |
11 Apr 2023 | AA | Micro company accounts made up to 31 December 2022 | |
05 Dec 2022 | CS01 | Confirmation statement made on 3 December 2022 with no updates | |
01 Apr 2022 | AA | Micro company accounts made up to 31 December 2021 | |
03 Dec 2021 | CS01 | Confirmation statement made on 3 December 2021 with no updates | |
20 May 2021 | AA | Micro company accounts made up to 31 December 2020 | |
03 Dec 2020 | CS01 | Confirmation statement made on 3 December 2020 with no updates | |
16 Jun 2020 | AA | Micro company accounts made up to 31 December 2019 | |
09 Dec 2019 | CS01 | Confirmation statement made on 3 December 2019 with no updates | |
15 May 2019 | AA | Micro company accounts made up to 31 December 2018 | |
17 Dec 2018 | CS01 | Confirmation statement made on 3 December 2018 with no updates | |
17 Dec 2018 | PSC04 | Change of details for Mr Christopher Holroyd as a person with significant control on 14 December 2018 | |
14 Dec 2018 | PSC04 | Change of details for Mrs Nicola Holroyd as a person with significant control on 14 December 2018 | |
14 Dec 2018 | CH01 | Director's details changed for Mrs Nicola Holroyd on 14 December 2018 | |
14 Dec 2018 | CH01 | Director's details changed for Mr Christopher Holroyd on 14 December 2018 | |
14 Dec 2018 | PSC04 | Change of details for Mr Christopher Holroyd as a person with significant control on 14 December 2018 | |
04 Dec 2017 | NEWINC |
Incorporation
Statement of capital on 2017-12-04
|